866-997-4948(US-Canada Toll Free)

Glaukos Corporation - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Dec 2012

Category :

Surgical Equipment

No. of Pages : 28 Pages


Glaukos Corporation (Glaukos) is an ophthalmic medical device company. Glaukos undertakes research and development of micro technologies to improve glaucoma therapy. Its portfolio includes microstent devices to treat glaucoma such as iStent Trabecular Micro-Bypass stent for the treatment of mild- tomoderate open-angle glaucoma. iStent is used in conjunction with cataract surgery. The company is headquartered in Orange County, California, the US.

The company plans to expand its product portfolio as recently it introduced the FDA approved iStent Trabecular Micro-Bypass Stent System, which is the first device approved for use in combination with cataract surgery to reduce pressure inside the eye in adult patients.

This report is a source for data, analysis and actionable intelligence on the Glaukos Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Contents 

Table of Contents 2
List of Tables 3
List of Figures 4
Key Facts 5
Glaukos Corporation - Major Products and Services 6
Glaukos Corporation Pipeline Products by Equipment Type 7
Glaukos Corporation Pipeline Products by Development Stage 9
Glaukos Corporation Pipeline Products by Therapy Area 10
Glaukos Corporation Pipeline Products by Trial Phase 12
GTS400 13
GTS400 Product Status 13
GTS400 Product Description 13
GTS400 Product Patent Details 13
iStent Inject 18
iStent Inject Product Status 18
iStent Inject Product Description 18
iStent Supra 19
iStent Supra Product Status 19
iStent Supra Product Description 19
iStent Supra Clinical Trial 19
iStent Supra Product Patent Details 20
Glaukos Corporation - Key Competitors 25
Glaukos Corporation - Key Employees 26
Glaukos Corporation - Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Table

List of Tables
Glaukos Corporation, Key Facts 1
Glaukos Corporation Key Pipeline Products by Equipment Type 1
Glaukos Corporation Key Pipeline Products by Therapy Area 1
Glaukos Corporation Key Pipeline Products by Development Stage 1
Glaukos Corporation Key Pipeline Products by Trial Phase 1
Glaukos Corporation, Key Facts 5
Glaukos Corporation, Major Products and Services 6
Glaukos Corporation Number of Pipeline Products by Equipment Type 7
Glaukos Corporation Pipeline Products by Equipment Type 8
Glaukos Corporation Number of Pipeline Products by Development Stage 9
Glaukos Corporation Pipeline Products by Development Stage 9
Glaukos Corporation Number of Pipeline Products by Therapy Area 10
Glaukos Corporation Pipeline Products by Therapy Area 11
Glaukos Corporation Number of Pipeline Products by Trial Phase 12
Glaukos Corporation Pipeline Products by Trial Phase 12
GTS400 - Product Status 13
GTS400 - Product Description 13
GTS400 - Patent Details1 13
GTS400 - Patent Details2 14
GTS400 - Patent Details3 14
GTS400 - Patent Details4 15
GTS400 - Patent Details5 15
GTS400 - Patent Details6 16
GTS400 - Patent Details7 16
GTS400 - Patent Details8 17
iStent Inject - Product Status 18
iStent Inject - Product Description 18
iStent Supra - Product Status 19
iStent Supra - Product Description 19
iStent Supra - A Prospective, Randomized, Controlled, Parallel Groups Evaluation of Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty 19
iStent Supra - Patent Details1 20
iStent Supra - Patent Details2 21
iStent Supra - Patent Details3 21
iStent Supra - Patent Details4 22
iStent Supra - Patent Details5 22
iStent Supra - Patent Details6 23
iStent Supra - Patent Details7 23
iStent Supra - Patent Details8 24
Glaukos Corporation, Key Employees 26

List of Chart

List of Figures
Glaukos Corporation Pipeline Products by Equipment Type 7
Glaukos Corporation Pipeline Products by Development Stage 9
Glaukos Corporation Pipeline Products by Therapy Area 10
Glaukos Corporation Pipeline Products by Trial Phase 12

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *